Article
Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma.
The Journal of cell biology - 16 Oct 2000
Suga Y, Jarnik M, Attar P S, Longley M A, Bundman D, Steven A C, Koch P J, Roop D R
Abstract excerpt
Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic mice expressing a COOH-terminal truncated form of loricrin that is similar to the protein expressed in VS and PSEK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
